knowledge -WSS

knowledge

author：leisure time 2025-10-01 01:50:12 - browse：43193

WASHINGTON, DC - NOVEMBER 27: U.S. President Joe Biden speaks about supply chain resilience during an event in the Indian Treaty Room at the Eisenhower Executive Office Building on November 27, 2023 in Washington, DC. — President Biden spoke about supply chain resilience and drug shortages. Alex Wong/Getty Images

WASHINGTON — President Biden’s new plan to curb drug shortages by boosting domestic drug production won’t expand the supply of the chemotherapies that are currently in shortage, an administration official confirmed. The limited scope surprised experts, who told STAT Biden could have included those drugs in the effort.

The 15 cancer drugs in short supply account for only a little more than 10% of the drugs on FDA’s shortage list. But chemotherapies are far more crucial than many other drugs experiencing shortages, which include injections of amino acids and multivitamins, and sterile water. Gut-wrenching stories about cancer patients being switched to less-effective drugs have caused cancer doctors to agitate for government solutions.

Biden announced last week that he plans to use the Defense Production Act to get companies to make essential medicines and their ingredients in the United States. The administration will spend $35 million to boost domestic production of key starting materials for drugs that hospitals commonly use and are prone to shortages.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： Studies point to risks of excluding people with obesity from drug trials

hotspot

WSS

Neuroscience startup Neumora files for IPO

CDC advisory panel says seniors 'may' get RSV vaccine

Australia’s approach to dialysis celebrates life

Psilocybin's anti

The EU Joint Clinical Assessment needs to live up to its promise

Unicorn down: Following layoffs, Biofourmis CEO quietly departs

focus

knowledge

hotspot

Medical records are filled with copy

Complete sequence of Y chromosome published for first time

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

In science, is the line between industry and academia shifting?

FDA approval of Sarepta Duchenne genetic therapy gives me hope

How climate

BioMarin wins approval for gene therapy to treat hemophilia A

As pharma fights Medicare drug negotiation, hospitals, docs silent

Cancer drug shortages should be causing more outrage

Unicorn down: Following layoffs, Biofourmis CEO quietly departs

knowledge

How Long Island became the ‘eugenics capital of the world’

Medicare explains how it will choose drugs for negotiation

HHS leader on health, climate change and biopharma emissions

Australia’s approach to dialysis celebrates life

Appeals court upholds limits to abortion pill

NIH confirmation hearing shows politicization of research

hotspot

hotspot

entertainment

hotspot